Singapore markets close in 20 minutes

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
973.16-11.86 (-1.20%)
At close: 04:00PM EDT
972.80 -0.36 (-0.04%)
After hours: 07:02PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
2,730,000
3,105,900
2,885,600
2,193,700
-
Other short-term investments
8,114,800
4,636,400
2,809,100
1,393,300
-
Total cash
10,844,800
7,742,300
5,694,700
3,587,000
-
Net receivables
5,667,300
5,328,700
6,036,500
4,114,700
-
Inventory
2,580,500
2,401,900
1,951,300
1,916,600
-
Other current assets
386,600
411,200
332,400
160,800
-
Total current assets
19,479,200
15,884,100
14,014,900
9,779,100
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
6,125,200
5,432,200
4,880,300
4,352,700
-
Accumulated depreciation
-1,978,800
-1,669,200
-1,398,100
-1,131,100
-
Net property, plant and equipment
4,146,400
3,763,000
3,482,200
3,221,600
-
Equity and other investments
5,396,500
6,591,800
6,838,000
3,135,600
-
Intangible assets
1,038,600
915,500
-
-
-
Other long-term assets
444,100
336,400
216,100
168,100
-
Total non-current assets
13,601,000
13,330,400
11,419,900
7,384,200
-
Total assets
33,080,200
29,214,500
25,434,800
17,163,300
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
606,600
589,200
564,000
475,500
-
Taxes payable
-
300
326,300
19,500
49,400
Accrued liabilities
2,357,900
2,074,200
1,593,100
1,608,600
-
Deferred revenues
458,900
477,900
442,000
577,700
-
Other current liabilities
-
-
-
122,400
85,000
Total current liabilities
3,423,400
3,141,300
3,932,500
2,697,400
-
Non-current liabilities
Long-term debt
1,982,900
1,981,400
1,980,000
1,978,500
-
Deferred revenues
126,700
69,800
73,300
57,800
-
Other long-term liabilities
854,100
638,000
680,200
687,100
-
Total non-current liabilities
3,683,700
3,409,200
2,733,500
3,440,600
-
Total liabilities
7,107,100
6,550,500
6,666,000
6,138,000
-
Stockholders' equity
Common stock
100
100
100
100
-
Retained earnings
27,260,300
23,306,700
18,968,300
10,893,000
-
Accumulated other comprehensive income
-80,900
-238,800
-26,200
29,300
-
Total stockholders' equity
25,973,100
22,664,000
18,768,800
11,025,300
-
Total liabilities and stockholders' equity
33,080,200
29,214,500
25,434,800
17,163,300
-